Review Article
Odanacatib, a New Drug for the Treatment of Osteoporosis: Review of the Results in Postmenopausal Women
Table 1
Effect of 50 mg of odanacatib on formation markers and resorption at 12, 24, and 36 months.
| ||||||||||||||||||||||||||||
NTx/Cr: N-terminal telopeptide of type I collagen normalized to creatinine. BSAP: bone-specific alkaline phosphatase. CTx: carboxyterminal telopeptide of type I collagen. |